[1] Manier S, Sacco A, Leleu X,et al.Bone marrow microenvironment in multiple myeloma progression.J Biomed Biotechnol. 2012;2012:157496.
[2] Ribatti D, Nico B, Vacca A.Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma.Oncogene. 2006;25(31):4257-4266.
[3] Zhang T, Lee YW, Rui YF,et al.Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors.Stem Cell Res Ther. 2013; 4(3):70.
[4] Kéramidas M, de Fraipont F, Karageorgis A,et al.The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis.Stem Cell Res Ther. 2013;4(2):41.
[5] Pittenger MF, Mackay AM, Beck SC,et al. Multilineage potential of adult human mesenchymal stem cells.Science. 1999;284(5411):143-147.
[6] Kinnaird T, Stabile E, Burnett MS,et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.Circ Res. 2004;94(5):678-685.
[7] Otsu K, Das S, Houser SD,et al. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells.Blood. 2009;113(18):4197-4205.
[8] Beckermann BM, Kallifatidis G, Groth A,et al.VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma.Br J Cancer. 2008; 99(4):622-631.
[9] Zhang K, Shi B, Chen J,et al. Bone marrow mesenchymal stem cells induce angiogenesis and promote bladder cancer growth in a rabbit model.Urol Int. 2010;84(1):94-99.
[10] Wang X, Zhang Z, Yao C.Angiogenic activity of mesenchymal stem cells in multiple myeloma.Cancer Invest. 2011;29(1): 37-41.
[11] Podar K, Tai YT, Davies FE,et al.Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration.Blood. 2001;98(2): 428-435.
[12] Arnulf B, Lecourt S, Soulier J,et al. Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma.Leukemia. 2007; 21(1):158-163.
[13] Kyle RA, Rajkumar SV.Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23(1):3-9.
[14] Carmeliet P.Angiogenesis in health and disease.Nat Med. 2003; 9(6):653-660.
[15] Carmeliet P, Jain RK.Angiogenesis in cancer and other diseases.Nature. 2000;407(6801):249-257.
[16] Bray F, Sankila R, Ferlay J,et al. Estimates of cancer incidence and mortality in Europe in 1995.Eur J Cancer. 2002;38(1):99-166.
[17] Vacca A, Ribatti D, Roncali L,et al. Bone marrow angiogenesis and progression in multiple myeloma.Br J Haematol. 1994;87(3):503-508.
[18] Alexandrakis MG, Passam FH, Sfiridaki A,et al. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.Am J Hematol. 2003;72(4):229-233.
[19] Bolkun L, Lemancewicz D, Sobolewski K,et al.The evaluation of angiogenesis and matrix metalloproteinase-2 secretion in bone marrow of multiple myeloma patients before and after the treatment.Adv Med Sci. 2013;58(1):118-125.
[20] Salvolini E, Orciani M, Vignini A,et al.Skin-derived mesenchymal stem cells (S-MSCs) induce endothelial cell activation by paracrine mechanisms.Exp Dermatol. 2010; 19(9):848-850.
[21] Vacca A, Ria R, Ribatti D,et al.A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.Haematologica. 2003;88(2):176-185.
[22] Menu E, Kooijman R, Van Valckenborgh E,et al.Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model.Br J Cancer. 2004; 90(5):1076-1083.
[23] Dankbar B, Padró T, Leo R,et al.Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.Blood. 2000;95(8): 2630-2636.
[24] Borset M, Lien E, Espevik T,et al.Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines.J Biol Chem. 1996; 271(40):24655-24661.
[25] Com?a S, Ciuculescu F, Henschler R,et al.MCF7-MSC co-culture assay: approach to assess the co-operation between MCF-7s and MSCs in tumor-induced angiogenesis. Rom J Morphol Embryol. 2011;52(3 Suppl): 1071-1076.
[26] Honczarenko M, Le Y, Swierkowski M,et al. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors.Stem Cells. 2006;24(4): 1030-1041.
[27] Com?a S, Ciuculescu F, Raica M.Mesenchymal stem cell-tumor cell cooperation in breast cancer vasculogenesis. Mol Med Rep. 2012;5(5):1175-1180.
[28] Corre J, Mahtouk K, Attal M,et al. Bone marrow mesenchymal stem cells are abnormal in multiple myeloma.Leukemia. 2007; 21(5):1079-1088.
[29] Li B, Shi M, Li J, et al. Elevated tumor necrosis factor-alpha suppresses TAZ expression and impairs osteogenic potential of Flk-1+ mesenchymal stem cells in patients with multiple myeloma.Stem Cells Dev. 2007;16(6):921-930.
[30] Arnulf B, Lecourt S, Soulier J,et al. Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma.Leukemia. 2007; 21(1):158-163.
[31] Garayoa M, Garcia JL, Santamaria C,et al. Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors. Leukemia. 2009;23(8):1515-1527.
[32] Sun B, Zhang S, Ni C,et al. Correlation between melanoma angiogenesis and the mesenchymal stem cells and endothelial progenitor cells derived from bone marrow.Stem Cells Dev. 2005;14(3):292-298.
[33] Imaizumi T, Itaya H, Nasu S,et al. Expression of vascular endothelial growth factor in human umbilical vein endothelial cells stimulated with interleukin-1alpha--an autocrine regulation of angiogenesis and inflammatory reactions. Thromb Haemost. 2000;83(6):949-955.
[34] Kojima-Yuasa A, Hua JJ, Kennedy DO,et al. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Life Sci. 2003;73(10):1299-1313.
[35] Aparicio S, Sawant S, Lara N,et al. Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF.Biochem Biophys Res Commun. 2005;326(2):387-394.
[36] Zhang B, Yang S, Zhang Y,et al.Co-culture of mesenchymal stem cells with umbilical vein endothelial cells under hypoxic condition.J Huazhong Univ Sci Technolog Med Sci. 2012; 32(2):173-180.
[37] Oswald J, Boxberger S, Jørgensen B,et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004;22(3):377-384.
[38] Guo X, Li YL.Cytological basis and significance of mesenchymal stem cells differentiated into endothelial cells.Sheng Li Ke Xue Jin Zhan. 2005;36(3):204-208.
[39] Pankajakshan D, Kansal V, Agrawal DK.In vitro differentiation of bone marrow derived porcine mesenchymal stem cells to endothelial cells.J Tissue Eng Regen Med. 2013;7(11): 911-920.
[40] Rahbarghazi R, Nassiri SM, Khazraiinia P,et al.Juxtacrine and paracrine interactions of rat marrow-derived mesenchymal stem cells, muscle-derived satellite cells, and neonatal cardiomyocytes with endothelial cells in angiogenesis dynamics. Stem Cells Dev. 2013;22(6):855-865.
[41] Feng B, Chen L.Review of mesenchymal stem cells and tumors: executioner or coconspirator. Cancer Biother Radiopharm. 2009;24(6):717-721. |